Skip to main content
Top
Published in: Pathology & Oncology Research 2/2011

01-06-2011 | Research

Integrating Functional MRI Information into Radiotherapy Planning of CNS Tumors-Early Experiences

Authors: Árpád Kovács, Lilla Tóth, Csaba Glavák, Ferenc Lakosi, Janaki Hadjiev, Gábor Bajzik, Csaba Vandulek, Imre Repa

Published in: Pathology & Oncology Research | Issue 2/2011

Login to get access

Abstract

The purpose of our study was to examine the integration of functional MRI (fMRI) information into 3D based planning process of the central nervous system (CNS) malignancies. Between 01.01.2008 and 01.12.2008 four patients with astrocytoma were enrolled to this study. Before the planning process conventional planning CT, postoperative MR and individual functional MRI examinations were delivered. For the functional MRI examination the following four types of stimulus were applied: acoustic, visual, somatosensory and numeral. Three different theoretical planning situations were applied and compared: 3D conformal plan without fMRI information, 3D conformal plan with fMRI information and IMRT plan with fMRI information. For plan comparison DVH analysis, and NTCP model were used. fMRI based OR definition resulted in 4 additional OR’s in the contouring process. As these cases demonstrate, an average of 50% dose reduction was achieved in OR, OR2 and OR3 with IMRT and fMRI based 3D planning, especially in case of midline localization and big tumor extent. IMRT provides additional sparing effect in the optic tract and brainstem, especially for localizations close to the midline. Our results demonstrated that using fMRI information in conventional 3D based treatment planning potentially benefits significant dose reduction in critical organs, with no compromise in PTV coverage. fMRI can be widely used even in low grade cases (long life expectancies, lower acute and late toxicity in radiotherapy) and in cases with high grade astrocytomas or metastases (higher dose to PTV with better risk organ sparing in radiotherapy).
Literature
1.
go back to reference Alvarez R, Liney G, Beavis A (2006) Repeatability of Functional MRI for Conformal Avoidance Radiotherapy Planning. J Magn Reson Imaging 23:108–114CrossRef Alvarez R, Liney G, Beavis A (2006) Repeatability of Functional MRI for Conformal Avoidance Radiotherapy Planning. J Magn Reson Imaging 23:108–114CrossRef
2.
go back to reference Aoyama H, Kamada K, Shirato H et al (2004) Integration of mfunctional brain information into stereotactic irradiation treatment planning using magnetoencephalography and magnetic resonance axonography. Int J Radiat Oncol Biol Phys 58:1177–1183PubMedCrossRef Aoyama H, Kamada K, Shirato H et al (2004) Integration of mfunctional brain information into stereotactic irradiation treatment planning using magnetoencephalography and magnetic resonance axonography. Int J Radiat Oncol Biol Phys 58:1177–1183PubMedCrossRef
3.
go back to reference Bleehen NM, Stenning SP (1991) A medical research council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. Br J Cancer 64:769–774PubMedCrossRef Bleehen NM, Stenning SP (1991) A medical research council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. Br J Cancer 64:769–774PubMedCrossRef
4.
go back to reference Burman C, Kutcher GJ, Emami B, Goitein M (1991) Fitting of tissue tolerance data to analytic function: improving the therapeutic ratio. Int J Radiat Oncol Biol Phys 21:123–135PubMed Burman C, Kutcher GJ, Emami B, Goitein M (1991) Fitting of tissue tolerance data to analytic function: improving the therapeutic ratio. Int J Radiat Oncol Biol Phys 21:123–135PubMed
5.
go back to reference Chang J, Kowalski A, Hou B, Narayana A (2008) Feasibility Study of Intensity-Modulated Radiotherapy (IMRT) treatment planning using brain functional MRI. Med Dosim 33(1):42–47PubMedCrossRef Chang J, Kowalski A, Hou B, Narayana A (2008) Feasibility Study of Intensity-Modulated Radiotherapy (IMRT) treatment planning using brain functional MRI. Med Dosim 33(1):42–47PubMedCrossRef
6.
go back to reference Clark BG et al (1998) The integral biologically effective dose to predict brain stem toxicity of hypofractionated stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 40:667–675PubMedCrossRef Clark BG et al (1998) The integral biologically effective dose to predict brain stem toxicity of hypofractionated stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 40:667–675PubMedCrossRef
7.
go back to reference Emami B et al (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109–122PubMed Emami B et al (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109–122PubMed
8.
go back to reference Flickinger JC, Kondziolka D, Lunsford LD et al (2000) Development of a model to predict permanent symptomatic postradiosurgery. Int J Radiat Oncol Biol Phys 46:1143–1148PubMedCrossRef Flickinger JC, Kondziolka D, Lunsford LD et al (2000) Development of a model to predict permanent symptomatic postradiosurgery. Int J Radiat Oncol Biol Phys 46:1143–1148PubMedCrossRef
9.
10.
go back to reference Lee SW, Fraass BA, Marsh LH et al (1999) Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study. Int J Radiat Oncol Biol Phys 43:79–88PubMedCrossRef Lee SW, Fraass BA, Marsh LH et al (1999) Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study. Int J Radiat Oncol Biol Phys 43:79–88PubMedCrossRef
11.
go back to reference Liu WC, Schulder M, Narra V et al (2000) Functional magnetic resonance imaging aided radiation treatment planning. Med Phys 27:1563–1572PubMedCrossRef Liu WC, Schulder M, Narra V et al (2000) Functional magnetic resonance imaging aided radiation treatment planning. Med Phys 27:1563–1572PubMedCrossRef
12.
go back to reference Marks JE et al (1980) Cerebral radionecrosis: incidence and risk in relation to dose, time fractionation and volume. Int J Radiat Oncol Biol Phys 7:243–252 Marks JE et al (1980) Cerebral radionecrosis: incidence and risk in relation to dose, time fractionation and volume. Int J Radiat Oncol Biol Phys 7:243–252
13.
go back to reference Moonen CTW, Bandettini PA (eds) (1999) Functional MRI1. Springer-Verlag, Berlin Moonen CTW, Bandettini PA (eds) (1999) Functional MRI1. Springer-Verlag, Berlin
14.
go back to reference Nelson DF, Diener-West M, Horton J et al (1988) Combined modality approach to treatment of malignant gliomas - Re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: A joint study of the radiation therapy oncology group and the eastern cooperative oncology group. NCI Monogr 279–284 Nelson DF, Diener-West M, Horton J et al (1988) Combined modality approach to treatment of malignant gliomas - Re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: A joint study of the radiation therapy oncology group and the eastern cooperative oncology group. NCI Monogr 279–284
15.
go back to reference Rowinsky EK (1997) Paclitaxel pharmacology and other tumor types. Semin Oncol 24:S19-1–S19-12 Rowinsky EK (1997) Paclitaxel pharmacology and other tumor types. Semin Oncol 24:S19-1–S19-12
16.
go back to reference Teh BS, Mai WY, Grant WH et al (2002) Intensity modulated radiotherapy (IMRT) decreases treatment-related morbidity and potentially enhances tumor control. Cancer Invest 20:437–451PubMedCrossRef Teh BS, Mai WY, Grant WH et al (2002) Intensity modulated radiotherapy (IMRT) decreases treatment-related morbidity and potentially enhances tumor control. Cancer Invest 20:437–451PubMedCrossRef
17.
go back to reference Voges J, Treuer H, Sturm V et al (1996) Risk analysis of linear radiosurgery. Int J Radiat Oncol Biol Phys 36:1055–1063PubMedCrossRef Voges J, Treuer H, Sturm V et al (1996) Risk analysis of linear radiosurgery. Int J Radiat Oncol Biol Phys 36:1055–1063PubMedCrossRef
18.
go back to reference Walker MD, Alexander E, Hunt WE et al (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 49:333–343PubMedCrossRef Walker MD, Alexander E, Hunt WE et al (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 49:333–343PubMedCrossRef
Metadata
Title
Integrating Functional MRI Information into Radiotherapy Planning of CNS Tumors-Early Experiences
Authors
Árpád Kovács
Lilla Tóth
Csaba Glavák
Ferenc Lakosi
Janaki Hadjiev
Gábor Bajzik
Csaba Vandulek
Imre Repa
Publication date
01-06-2011
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 2/2011
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-010-9298-y

Other articles of this Issue 2/2011

Pathology & Oncology Research 2/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine